Flatulence News and Research

RSS
Flatulence is the expulsion through the rectum of a mixture of gases that are byproducts of the digestion process of mammals and other animals.
Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Progenics third quarter net loss increases to $17.1 million

Progenics third quarter net loss increases to $17.1 million

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Positive results from linaclotide Phase 3 trial in patients with IBS-C

Positive results from linaclotide Phase 3 trial in patients with IBS-C

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

Salix to discuss XIFAXAN therapy for hepatic encephalopathy at AASLD 2010 Annual Meeting

FDA approves NUEDEXTA capsules for pseudobulbar affect

FDA approves NUEDEXTA capsules for pseudobulbar affect

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

FDA, EMA and Health Canada approve Progenics' RELISTOR in pre-filled syringes

FDA, EMA and Health Canada approve Progenics' RELISTOR in pre-filled syringes

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Research on gut mucosa enables effective drug treatment for irritable bowel syndrome

Research on gut mucosa enables effective drug treatment for irritable bowel syndrome

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Progenics second-quarter total revenue decreases to $2.3 million

Progenics second-quarter total revenue decreases to $2.3 million

Progenics announces EMA CHMP positive opinion for RELISTOR in pre-filled syringes

Progenics announces EMA CHMP positive opinion for RELISTOR in pre-filled syringes

Genzyme accepts CMS decision for delaying Renvela administration to dialysis patients

Genzyme accepts CMS decision for delaying Renvela administration to dialysis patients

Polyethylene glycol "works a bit better" than lactulose for chronic constipation: Study

Polyethylene glycol "works a bit better" than lactulose for chronic constipation: Study